CHMP recommends approval of Galderma’s Nemolizumab for atopic dermatitis
CHMP recommends approval of Galderma’s Nemolizumab for atopic dermatitis Galderma announced that...
Read MorePosted by fourthwave999@gmail.com | Dec 17, 2024 | All, News
CHMP recommends approval of Galderma’s Nemolizumab for atopic dermatitis Galderma announced that...
Read MorePosted by fourthwave999@gmail.com | Dec 16, 2024 | All, News
Safic-Alcan Acquires Majority Stake in Avees Biocos Safic-Alcan, a major distributor of specialty...
Read MorePosted by fourthwave999@gmail.com | Dec 16, 2024 | All, News
Honasa Consumer Dismisses Claims of Rs 300 Crore Unsold Inventory as Misinformation Honasa...
Read MorePosted by fourthwave999@gmail.com | Dec 16, 2024 | All, Marketing
Who the e.l.f. did it? e.l.f. Cosmetics Launches “Cosmetic Criminals” True Crime...
Read MorePosted by fourthwave999@gmail.com | Dec 16, 2024 | All, Regulations
DCGI warns cosmetic brands on overlapping claims with pharma products The Drugs Controller General...
Read MoreJoin our mailing list to receive the latest news and updates from Cosmetics Industry.